| BioCrine AB Patent applications |
| Patent application number | Title | Published |
|---|
| 20110318325 | Inositol Pyrophosphates Determine Exocytotic Capacity - The invention provides reagents and methods for treating type II diabetes, as well as methods for identifying compounds for treating type II diabetes. | 12-29-2011 |
| 20110287029 | INHIBITION OF THE BETA3 SUBUNIT OF L-TYPE CA2+ CHANNELS - The present invention provides reagents and methods for identifying inhibitors of the L-type Ca | 11-24-2011 |
| 20110244509 | ApoIII and the Treatment and Diagnosis of Diabetes - The present invention provides methods of identifying candidate compounds for the treatment of type I diabetes comprising contacting pancreatic β cells with an amount of apolipoprotein CIII (“apoCIII”) effective to increase intracellular calcium concentration, in the presence of one or more test compounds, and identifying those test compounds that inhibit an apoCIII-induced increase in intracellular calcium concentration in the pancreatic β cells. The present invention also provides methods for treating patients with type I diabetes comprising administering to the patient an amount effective of an inhibitor of apoCIII to reduce apoCIII-induced increase in intracellular calcium concentration in pancreatic β cells. | 10-06-2011 |
| 20110092577 | Inositol Pyrophosphates Determine Exocytotic Capacity - The invention provides reagents and methods for treating type II diabetes, as well as methods for identifying compounds for treating type II diabetes. | 04-21-2011 |
| 20110064724 | Methods for Identifying Compounds for the Treatment of Type 1 Diabetes - The present invention provides methods of identifying candidate compounds for the treatment of type I diabetes comprising contacting pancreatic β cells with an amount of apolipoprotein CIII (“apoCIII”) effective to increase intracellular calcium concentration, in the presence of one or more test compounds, and identifying those test compounds that inhibit an apoCIII-induced increase in intracellular calcium concentration in the pancreatic β cells. The present invention also provides methods for treating patients with type I diabetes comprising administering to the patient an amount effective of an inhibitor of apoCIII to reduce apoCIII-induced increase in intracellular calcium concentration in pancreatic β cells. | 03-17-2011 |
| 20090074743 | Inositol Pyrophosphates Determine Exocytotic Capacity - The invention provides reagents and methods for treating type II diabetes, as well as methods for identifying compounds for treating type II diabetes. | 03-19-2009 |
| 20090060843 | Non-Invasive In Vivo Imaging and Methods for Treating Type I Diabetes - The present invention provides novel drug discovery platforms and methods for treating type I diabetes. | 03-05-2009 |
